Pain Management
Pharmacogenomic (PGx) Testing helps uncover the biological reasons behind different outcomes to medications by linking genetic variability to drug responses and outcomes. By utilizing PGx testing, pain management providers can devise individualized pain management regiments to alleviate acute and chronic pain and simultaneously reduce narcotics use. PGx testing has been shown to reduce narcotic use by 50%, increase medication adherence and reduce ED visits by approximately 70%.
Find out what other leading institutions are saying about CQuentia.
Contact us to enlist your institution in a no-risk trial of our PGx program and be our partner in improving global health care by accelerating the impact of genomics on patient care.
CQuentia, more than a lab, more than a test. The leaders in the new frontier of genomic testing and personalized medicine.